Behavioral Engineering for Ward Personnel

1967 ◽  
Vol 12 (8) ◽  
pp. 426-427
Author(s):  
J. S. BIRNBRAUER
1968 ◽  
Vol 1 (2) ◽  
pp. 99-108 ◽  
Author(s):  
N. Azrin ◽  
H. Rubin ◽  
F. O'Brien ◽  
T. Ayllon ◽  
D. Roll

2016 ◽  
Vol 33 (S1) ◽  
pp. S61-S61
Author(s):  
G. Mattei ◽  
N. Colombini ◽  
S. Ferrari ◽  
G.M. Galeazzi

IntroductionMultimorbidity and polipharmacotherapy are crucial features influencing the psychiatrist's prescription in the consultation-liaison psychiatry (CLP) setting.Aimsto provide an example of computer-assisted decision-making in psychotropic prescriptions and to provide hints for developing pharmacological treatment strategies in the CLP setting.MethodsCase report. A clinical vignette is presented, followed by a review of available online computer-assisted prescription software.ResultsA woman in her seventies was repeatedly referred for psychiatric consultation. Eleven different medications were administered daily, because of multimorbidity. A diagnosis of distymia was established, with comorbid mixed pain (partly fulfilling the criteria of somatic symptom disorder) and substance use disorder (opioids). After the first assessment, six follow-up visits were needed during hospitalization. Mirtazapine and benzodiazepines were introduced. Beside the pharmacological intervention, conflict mediation was performed in the relationship with the patient, her relatives, the ward personnel and the GP, to develop a long-term rehabilitation project. Pros and cons of online computer-assisted prescription software were discussed together with the ward personnel, as well.ConclusionsComputer-assisted decision-making in psychotropic prescription is becoming more common and feasible. The use of available software may contribute to safety, effectiveness and cost-effectiveness of clinical decision-making. Risks are also possible: depending for example from regional differences in prescription indications, different guidelines, pharmacogenomics, frequency with which databases are updated, sponsorships, possible conflicts of interest, and real clinical significance of highlighted interactions – all issues the clinician willing to benefit from this modern tools should pay attention to.Disclosure of interestThe authors have not supplied their declaration of competing interest.


Diabetes ◽  
1968 ◽  
Vol 17 (5) ◽  
pp. 281-285 ◽  
Author(s):  
H. L. Dobson ◽  
R. Shaffer ◽  
R. Burns

1954 ◽  
Vol 54 (1) ◽  
pp. 53 ◽  
Author(s):  
Francoise R. Morimoto

1977 ◽  
Vol 22 (11) ◽  
pp. 831-832
Author(s):  
DOMINIC W. MASSARO

Sign in / Sign up

Export Citation Format

Share Document